Geode Capital Management
OPTR

Geode Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Geode Capital Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-223,628
Closed -$2.82M – 3802
2013
Q3 		$2.82M Buy
223,628
+20,823
+10% +$276K ﹤0.01% 1967
2013
Q2 		$2.94M Buy
+202,805
New +$2.95M ﹤0.01% 1789

Geode Capital Management's OPTR Position: Q4 2013 in Review

Geode Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 223,628 shares — an estimated $2.82M sold.

Geode Capital Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $2.94M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Geode Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Geode Capital Management sold 223,628 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.82M.
  • Geode Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Geode Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.94M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Geode Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.